Noesis Capital Mangement Corp Abbott Laboratories Transaction History

Noesis Capital Mangement Corp

$524 Billion
Q4 2024

A detailed history of Noesis Capital Mangement Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 2,289 shares of ABT stock, worth $295,441. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,289

Previous 2,115 8.23%

Holding current value

$295,441

Previous $241 Million 7.37%

% of portfolio

0.05%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$111.93 - $119.39 $19,475 - $20,773	174 Added 8.23%	2,289 $259 Million
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $211,648 - $249,844	2,115 New	2,115 $241 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $38,511 - $47,140	-427 Reduced 18.9%	1,832 $202 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $76,424 - $91,696	-800 Reduced 26.15%	2,259 $219 Million
Q2 2023 Jul 31, 2023	SELL	$100.78 - $112.29 $43,738 - $48,733	-434 Reduced 12.42%	3,059 $333 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $20,824 - $24,512	-215 Reduced 5.8%	3,493 $354 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $10,171 - $11,932	107 Added 2.97%	3,708 $407 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $1,548 - $1,792	16 Added 0.45%	3,601 $348 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $109,214 - $132,005	1,070 Added 42.54%	3,585 $389,000
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $83,462 - $101,777	-732 Reduced 22.54%	2,515 $297,000
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $1,617 - $1,980	-14 Reduced 0.43%	3,247 $456,000
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $121,559 - $134,480	1,042 Added 46.96%	3,261 $385,000
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $13,223 - $15,566	-125 Reduced 5.33%	2,219 $257,000
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $20,788 - $24,491	-191 Reduced 7.53%	2,344 $280,000
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $13,125 - $14,302	-125 Reduced 4.7%	2,535 $277,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $91,640 - $111,290	-1,000 Reduced 27.32%	2,660 $289,000
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $3,015 - $4,409	-48 Reduced 1.29%	3,660 $288,000
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $19,391 - $21,587	-247 Reduced 6.25%	3,708 $322,000
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $2,040 - $2,380	-28 Reduced 0.7%	3,955 $0
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $12,581 - $15,211	-190 Reduced 4.55%	3,983 $0
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $51,857 - $58,747	791 Added 23.39%	4,173 $302,000
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $9,121 - $11,004	-150 Reduced 4.25%	3,382 $248,000
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $3,684 - $4,066	-64 Reduced 1.78%	3,532 $215,000
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $112 - $127	2 Added 0.06%	3,596 $215,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $16,104 - $17,241	-300 Reduced 7.7%	3,594 $205,000
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $187,145 - $208,874	3,894	3,894 $208,000

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

News

Stay updated on Noesis Capital Mangement Corp with notifications on news.

Account

Noesis Capital Mangement Corp Abbott Laboratories Transaction History